Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center

被引:2
作者
Kaaroud, Hayet [1 ,2 ,3 ]
Harzallah, Amel [1 ,2 ,3 ]
Hajji, Mariem [1 ,2 ,3 ]
Chargui, Soumaya [1 ,2 ,3 ]
Barbouch, Samia [1 ,2 ,3 ]
Turki, Sami [1 ,2 ,3 ]
Trabelsi, Raja [1 ,2 ,3 ]
Goucha, Rim [2 ,3 ]
Ben Moussa, Fatma [3 ]
Ben Maiz, Hedi [3 ]
Ben Hamida, Fethi [1 ,2 ,3 ]
Abderrahim, Ezzeddine [1 ,2 ,3 ]
机构
[1] Charles Nicolle Hosp, Dept Med, Tunis, Tunisia
[2] Charles Nicolle Hosp, Lab Renal Pathol LR00SP01, Tunis, Tunisia
[3] Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
关键词
FAMILIAL MEDITERRANEAN FEVER; SYSTEMIC AMYLOIDOSIS; AA AMYLOIDOSIS; NATRIURETIC PEPTIDE; CHAIN AMYLOIDOSIS; PROTEIN; DIAGNOSIS; EXPERIENCE; SECONDARY; SURVIVAL;
D O I
10.1155/2022/8493479
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Renal amyloidosis is one of the main differential diagnoses of nephrotic proteinuria in adults and the elderly. The aim of this study with the most important series in our country is to contribute to the epidemiological, clinical, and etiological study of the renal amyloidosis. Methods. In a retrospective study carried out between 1975 and 2019, 310 cases of histologically proven and typed renal amyloidosis were selected for this study. Results. There were 209 men and 101 women with a mean age of 53.8 +/- 15.4 years (range, 17-84 years). Of the 310 cases, 255 (82.3%) were diagnosed with AA renal amyloidosis and 55 (17.7%) with non-AA amyloidosis. Infections were the main cause of AA amyloidosis, and tuberculosis was the most frequent etiology. The period from the onset of the underlying disease to diagnosis of the renal amyloidosis was an average of 177 months. The most frequent manifestations at the time of diagnosis were nephrotic syndrome (84%), chronic renal failure (30.3%), and end-stage renal disease (37.8%). After a medium follow-up of 16 months (range, 0-68 months), mortality occurred in 60 cases. Conclusions. Given the high frequency of AA amyloidosis in our country, awareness of the proper management of infectious and chronic inflammatory diseases remains a priority in reducing the occurrence of this serious disease.
引用
收藏
页数:9
相关论文
共 49 条
[1]  
Abdallah Emad, 2013, Saudi J Kidney Dis Transpl, V24, P950
[2]  
Andronesi AG, 2019, ROM J MORPHOL EMBRYO, V60, P1299
[3]   Advanced systemic amyloidosis secondary to metastatic renal cell carcinoma [J].
Asuncion Algarra, Maria ;
Juan Fita, Maria Jose ;
Sandiego, Sergio ;
Augusto Aguilar, Hector ;
Alvarez, Pablo ;
Quispe, Mateo ;
Salvador, Antonio ;
Egido, Adoracion ;
Lavernia, Javier ;
Machado, Isidro ;
Rubio-Briones, Jose ;
Angel Climent, Miguel .
ECANCERMEDICALSCIENCE, 2020, 14
[4]   SYSTEMIC AMYLOIDOSIS AND MALIGNANT DISEASE [J].
AZZOPARDI, JG ;
LEHNER, T .
JOURNAL OF CLINICAL PATHOLOGY, 1966, 19 (06) :539-+
[5]   A NOVEL ALLELIC VARIANT OF SERUM AMYLOID-A, SAA1-GAMMA - GENOMIC EVIDENCE, EVOLUTION, FREQUENCY, AND IMPLICATION AS A RISK FACTOR FOR REACTIVE SYSTEMIC AA-AMYLOIDOSIS [J].
BABA, S ;
MASAGO, SA ;
TAKAHASHI, T ;
KASAMA, T ;
SUGIMURA, H ;
TSUGANE, S ;
TSUTSUI, Y ;
SHIRASAWA, H .
HUMAN MOLECULAR GENETICS, 1995, 4 (06) :1083-1087
[6]  
Bakkaloglu A, 2004, J RHEUMATOL, V31, P1139
[7]  
Ben Maïz H, 2006, B ACAD NAT MED PARIS, V190, P403
[8]   Ostertag revisited: The inherited systemic amyloidoses without neuropathy [J].
Benson, MD .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2005, 12 (02) :75-87
[9]   The hereditary amyloidoses [J].
Benson, MD .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (06) :909-927
[10]   Leukocyte chemotactic factor 2: A novel renal amyloid protein [J].
Benson, Merrill D. ;
James, Sam ;
Scott, Katherine ;
Liepnieks, Juris J. ;
Kluve-Beckerman, Barbara .
KIDNEY INTERNATIONAL, 2008, 74 (02) :218-222